Mode
Text Size
Log in / Sign up

Luteolin suppresses neuroinflammation by modulating microglial activation and antioxidant defensesLuteolin Shows Promise for Brain Inflammation

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider luteolin as a potential anti-neuroinflammatory agent, but note its limited bioavailability and BBB permeability.

This systematic review synthesizes preclinical evidence on the role of luteolin in neuroinflammation associated with central nervous system disorders. The review focuses on luteolin's mechanisms of action, including suppression of aberrant microglial activation, modulation of pro-inflammatory signaling pathways, and enhancement of endogenous antioxidant defenses. The direction of effect is reported as beneficial, though no pooled effect sizes or quantitative data are provided.

The authors note significant limitations, including luteolin's limited oral bioavailability and restricted blood-brain barrier permeability, which may hinder clinical translation. The review does not report on study populations, sample sizes, comparators, or specific outcomes, and safety data are absent.

Given the preclinical nature of the evidence and the pharmacokinetic challenges, the findings should be interpreted cautiously. Further research is needed to determine whether luteolin can be effectively delivered to the central nervous system and whether these anti-inflammatory effects translate to clinical benefit in humans.

A systematic review of laboratory studies suggests that luteolin, a natural compound found in foods like celery, parsley, and green peppers, may help reduce brain inflammation. The review looked at how luteolin affects microglial cells, the immune cells of the brain. When these cells become overactive, they can cause inflammation that contributes to conditions like Alzheimer's and multiple sclerosis.

The findings show that luteolin can suppress the overactivation of microglial cells and reduce the release of inflammatory signals. It also boosts the brain's own antioxidant defenses. These effects could potentially protect against damage from chronic inflammation.

However, this research is still early. The studies were done in cells and animals, not in people. Luteolin also has two major challenges: it is not easily absorbed by the body, and it has trouble crossing the blood-brain barrier. This means that even if it works in a lab dish, it may not reach the brain in high enough amounts to have an effect.

What does this mean for you? While luteolin-rich foods are healthy, there is not enough evidence to recommend supplements for brain health. More human studies are needed to know if luteolin can truly help with brain inflammation.

What this means for you:
Luteolin may reduce brain inflammation, but human studies are needed.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
Neuroinflammation is a fundamental pathological hallmark driving the initiation and progression of various neurological disorders. Luteolin, a natural flavonoid abundant in medicinal plants, fruits, and vegetables, exerts multifaceted neuroprotective effects across diverse experimental disease models. Its beneficial activities are mediated through complementary mechanisms, including suppression of aberrant microglial activation, modulation of pro-inflammatory signaling pathways, and enhancement of endogenous antioxidant defenses. These integrated actions attenuate inflammatory mediator release, reduce oxidative stress-induced neuronal damage, and inhibit apoptosis, thereby counteracting neuroinflammation-driven pathology. This review synthesizes current knowledge on luteolin’s protective roles in central nervous system (CNS) disorders. It elucidates underlying molecular mechanisms, encompassing regulation of key signaling cascades such as NF-κB, MAPK, and Nrf2, as well as its impact on cellular processes including autophagy and mitochondrial function. Critical challenges hindering clinical translation—notably limited oral bioavailability and restricted blood-brain barrier (BBB) permeability—are systematically discussed to guide future research. A comprehensive understanding of luteolin’s pleiotropic pharmacological actions will not only enhance knowledge of its therapeutic potential but may also facilitate the development of novel preventive and therapeutic strategies for neuroinflammatory and neurodegenerative diseases.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.